1. Acknowledgement to Referees

   Acknowledgement to Referees 10 November 2017 Pages: 1929 - 1933

2. Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies

   • Julie Dyall
   • Robin Gross
   • Peter B. Jahrling

   Review Article 15 November 2017 Pages: 1935 - 1966

   

3. Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years

   • G. Voegeli
   • M. L. Cléry-Melin
   • P. Gorwood

   Systematic Review 02 November 2017 Pages: 1967 - 1986

   

4. Tofacitinib: A Review in Rheumatoid Arthritis

   • Sohita Dhillon

   Adis Drug Evaluation 14 November 2017 Pages: 1987 - 2001

5. Nonacog Beta Pegol: A Review in Haemophilia B

   • Yahiya Y. Syed

   Adis Drug Evaluation Open access 09 November 2017 Pages: 2003 - 2012

6. Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma

   • Hannah A. Blair

   Adis Drug Evaluation 10 November 2017 Pages: 2013 - 2024

   

7. Ticagrelor: A Review in Long Term Secondary Prevention of Cardiovascular Events

   • Zaina T. Al-Salama
   • Gillian M. Keating
   • Susan J. Keam

   Adis Drug Evaluation 18 November 2017 Pages: 2025 - 2036

   

8. Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer

   • James E. Frampton

   Adis Drug Evaluation 25 November 2017 Pages: 2037 - 2048

   

9. Aripiprazole Lauroxil: A Review in Schizophrenia

   • James E. Frampton

   Adis Drug Evaluation 25 November 2017 Pages: 2049 - 2056

10. Copanlisib: First Global Approval

    • Anthony Markham

    AdisInsight Report 10 November 2017 Pages: 2057 - 2062

    

11. Abemaciclib: First Global Approval

    • Esther S. Kim

    AdisInsight Report 11 November 2017 Pages: 2063 - 2070